|1.||Hosking, B C: 6 articles (05/2012 - 02/2009)|
|2.||Strehlau, G A: 4 articles (10/2010 - 02/2009)|
|3.||Rufener, Lucien: 3 articles (01/2014 - 01/2013)|
|4.||Stein, P A: 3 articles (04/2012 - 03/2009)|
|5.||Malikides, N: 3 articles (08/2009 - 02/2009)|
|6.||Skálová, Lenka: 2 articles (02/2015 - 10/2014)|
|7.||Szotáková, Barbora: 2 articles (02/2015 - 10/2014)|
|8.||Vokřál, Ivan: 2 articles (02/2015 - 10/2014)|
|9.||Stuchlíková, Lucie: 2 articles (02/2015 - 10/2014)|
|10.||Lamka, Jiří: 2 articles (02/2015 - 10/2014)|
11/01/2009 - "Monepantel when used under field conditions at a minimum dose rate of 2.5 mg/kg was highly effective against mixed-genus natural field infections of the major gastrointestinal nematode genera including Haemonchus, Teladorsagia (Ostertagia), Trichostrongylus, Nematodirus, Chabertia and Oesophagostomum. "
10/16/2010 - "The efficacy of monepantel against mixed-genus natural field infections of the major gastrointestinal nematodes was in agreement with similar studies conducted in Australia and New Zealand. "
05/25/2012 - "At necropsy it was determined that the untreated control sheep were additionally infected with developing fourth-stage Teladorsagia spp. larvae and this is the first published evidence on the efficacy of monepantel against natural infections of this parasite and stage. "
10/01/2014 - "Monepantel (MOP) is a new anthelmintic drug intended for the treatment and control of gastrointestinal roundworms (nematodes) infection and associated disease in sheep. "
05/25/2012 - "In conclusion, monepantel dosed orally at 2.5 mg/kg is a highly effective treatment against naturally acquired infections of inhibited and developing fourth-stage larvae of Teladorsagia spp."
12/01/2011 - "In vitro and in vivo efficacy of Monepantel (AAD 1566) against laboratory models of human intestinal nematode infections."
01/01/2014 - "Monepantel (MPL) is a new anthelmintic agent approved for the treatment of nematode infections in farm animals. "
01/22/2009 - "Efficacy of the amino-acetonitrile derivative, monepantel, against experimental and natural adult stage gastro-intestinal nematode infections in sheep."
02/05/2015 - "Monepantel (MOP), a new amino-acetonitrile anthelmintic for the treatment and control of gastrointestinal nematode infections and associated diseases in sheep, is approved and marketed as oral solution under the trade name Zolvix® (Novartis Animal Health Inc., Switzerland). "
07/01/2011 - "Recently, two new active ingredients became commercially available for the treatment of nematode infections in sheep, monepantel (Zolvix®) and derquantel, the latter used only in a formulated combination with the macrocyclic lactone, abamectin (Startect®). "
|3.||Body Weight (Weight, Body)
04/30/2012 - "A controlled, blinded study was undertaken in 6-week old, pre-weaned lambs to demonstrate the safety and efficacy against fourth-stage gastrointestinal nematode larvae, of monepantel administered per os at 2.5mg/kg body weight. "
01/01/2014 - "On day 0 pre-treatment, three groups of 15 lambs each were selected, blocked by fecal egg count level (FEC) and randomly assigned to one of the following: Group 0 = untreated control, Group 1 = treated with monepantel (Zolvix®, Novartis Animal Health Inc.) from stock previously purchased; Group 2 = treated with monepantel from stock provided by the supplier, at the recommended dose of 2.5 mg/kg of body weight. "
12/01/2010 - "Monepantel is a new oral anthelmintic drug for use in sheep at a dose of 2.5 mg active ingredient/kg body weight. "
07/01/2011 - "Eight infected sheep in each group were treated orally according to the product labels with 2.5 mg/kg body weight monepantel, 0.2 mg/kg abamectin, or with the combination of 2.0 mg/kg derquantel and 0.2 mg/kg abamectin. "
08/01/2009 - "This study demonstrated that this population of ewes could tolerate accidental overdoses of up to three times the MRD of monepantel or prolonged repetitive administration of overdoses. "
02/01/2009 - "This study demonstrated that this population of rams could tolerate accidental overdoses of up to three times the MRD of monepantel or prolonged repetitive administration at overdoses. "
02/01/2009 - "This study demonstrated that this population of lambs could tolerate accidental overdoses of up to five times the MRD of monepantel or prolonged repetitive administration at recommended doses or overdoses."
|2.||Veterinary Drugs (Veterinary Drug)
|4.||70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
|7.||Anti-Infective Agents (Microbicides)
|10.||abamectin (L 676)